Validity of European-centric cardiometabolic polygenic scores in multi-ancestry populations

Constantin‐Cristian Topriceanu(University College London), Victoria Garfield(MRC Unit for Lifelong Health and Ageing), Rohini Mathur(London School of Hygiene & Tropical Medicine), Nish Chaturvedi(Imperial College London)

European Journal of Human Genetics

January 5, 2024

10.1038/s41431-023-01517-3

Cited by 9

Related Papers

Vascular Risk Factors and Diabetic Neuropathy

|New England Journal of Medicine|2005|1.3k

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes

|The Lancet|1998|743

Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform

|The Lancet|2021|562

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

|The Lancet|2008|450

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

|The Lancet|2008|432